Knowledge and attitude factors associated with the prevalence of Tdap (tetanus, diphtheria, and acellular pertussis) booster vaccination in healthcare workers in a large academic hospital in Southern Italy in 2022: a cross-sectional study.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 24 02 2023
accepted: 13 06 2023
medline: 2 8 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: epublish

Résumé

In Europe, there is still suboptimal tetanus, diphtheria, and acellular pertussis (Tdap) booster coverage. This study aimed to assess coverage status, knowledge, and attitude on Tdap vaccination in healthcare workers (HcWs) of the University Hospital "Federico II" in Naples, Southern Italy, in 2022, to improve current vaccination strategies. A cross-sectional study was conducted using a validated anonymous questionnaire. Knowledge and attitude were measured as scores. Multivariable logistic and linear regression models were employed to identify correlates of Tdap booster and knowledge and attitude toward the vaccination, as appropriate. Models were controlled for age, sex, profession, department, and job seniority. A total of 206 questionnaires were administered among HcWs, and 143 (69.4%) were medical doctors. In total, 71 (34.47%) HcWs received the Tdap booster. Those who have worked 5-9 years at the hospital had a 78% lower likelihood of being vaccinated with the Tdap booster (5-9 years-OR: 0.22, CI: 0.06 | 0.85) as compared with newly hired HcWs. No differences in the average knowledge score were found. Other healthcare workers had a lower attitude as compared to medical doctors (Other-Coef. -2.15; CI: -4.14 | -0.15) and, as compared with those who worked in a clinical department, those who worked in a diagnostic-therapeutic department or medical management had 3.1 and 2.0 lower attitude scores, on average, respectively (diagnostic-therapeutic-Coef. -3.12, CI: -5.13 | -1.12; public health-Coef. -1.98, CI: -3.41 | -0.56). The study findings support the necessity to implement public health strategies and improve knowledge and attitude toward vaccinations and specifically highlight the importance of Tdap booster every 10 years as a prevention tool to protect high-risk populations.

Identifiants

pubmed: 37522000
doi: 10.3389/fpubh.2023.1173482
pmc: PMC10374026
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1173482

Informations de copyright

Copyright © 2023 Mercogliano, Fiorilla, Esposito, Sorrentino, Mirizzi, Parisi, Tajani, Buonocore, Triassi and Palladino.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Infect Control Hosp Epidemiol. 2007 May;28(5):537-43
pubmed: 17464912
Clin Infect Dis. 2006 Apr 1;42(7):981-8
pubmed: 16511764
Hum Vaccin Immunother. 2018 Jul 3;14(7):1573-1579
pubmed: 29863958
Infect Control Hosp Epidemiol. 2006 Jan;27(1):92-5
pubmed: 16418998
J Clin Med. 2023 Feb 21;12(5):
pubmed: 36902519
J Prev Med Hyg. 2019 Mar 29;60(1):E12-E17
pubmed: 31041405
Vaccines (Basel). 2020 Jul 11;8(3):
pubmed: 32664507
Am J Prev Med. 2018 Jan;54(1):119-123
pubmed: 29174081
Clin Infect Dis. 1995 Sep;21(3):639-42
pubmed: 8527557
Hum Vaccin Immunother. 2017 Feb;13(2):470-476
pubmed: 27924688
Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S89-S95
pubmed: 27130670
PLoS One. 2017 Aug 9;12(8):e0182510
pubmed: 28793335
Vaccine. 2019 Oct 31;37(46):6900-6906
pubmed: 31564452
Braz J Infect Dis. 2019 Jul - Aug;23(4):231-236
pubmed: 31351815
Hum Vaccin Immunother. 2015;11(1):95-100
pubmed: 25483521
Lancet Reg Health Eur. 2021 Jul;6:100112
pubmed: 34124707
Postgrad Med J. 2023 Jun 15;99(1172):520-528
pubmed: 37319159
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2208895119
pubmed: 36445971
Int J Environ Res Public Health. 2022 Apr 06;19(7):
pubmed: 35410091
Hum Vaccin Immunother. 2022 Dec 31;18(1):2014732
pubmed: 35172681
Am J Prev Med. 2017 Oct;53(4):537-546
pubmed: 28545743
MMWR Recomm Rep. 2011 Nov 25;60(RR-7):1-45
pubmed: 22108587
Lancet Reg Health West Pac. 2021 Dec;17:100303
pubmed: 34697610
Vaccine. 2013 Jun 10;31(26):2835-8
pubmed: 23623864
Epidemiol Infect. 2017 Oct;145(14):3085-3095
pubmed: 28885136
Pediatrics. 2006 Mar;117(3):965-78
pubmed: 16382131
Turk J Pediatr. 2018;60(3):290-297
pubmed: 30511542
Infect Control Hosp Epidemiol. 1999 Feb;20(2):120-3
pubmed: 10064216
Lancet Infect Dis. 2011 Jul;11(7):557-70
pubmed: 21600850
PeerJ. 2019 Aug 15;7:e7516
pubmed: 31435493
Epidemiol Prev. 2019 Jan-Feb;43(1):83-91
pubmed: 31111719
Vaccine. 2018 Jan 4;36(2):214-219
pubmed: 29217370
J Prev Med Hyg. 2020 Apr 02;61(1):E66-E75
pubmed: 32490271
Vaccine. 2014 Jan 23;32(5):572-8
pubmed: 24308960
Vaccine. 2016 Mar 14;34(12):1423-5
pubmed: 26562318
Hum Vaccin Immunother. 2017 May 4;13(5):1198-1206
pubmed: 28059668
Am J Infect Control. 2011 Aug;39(6):488-94
pubmed: 21288599
Clin Microbiol Rev. 2008 Jul;21(3):426-34
pubmed: 18625679

Auteurs

Michelangelo Mercogliano (M)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.

Claudio Fiorilla (C)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.

Federica Esposito (F)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.

Michele Sorrentino (M)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.

Pasquale Domenico Mirizzi (PD)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.

Antonio Parisi (A)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.

Andrea Tajani (A)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.

Gaetano Buonocore (G)

Clinical Directorate, University Hospital "Federico II" of Naples, Naples, Italy.

Maria Triassi (M)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.
Interdepartmental Research Center in Healthcare Management and Innovation in Healthcare (CIRMIS), Naples, Italy.

Raffaele Palladino (R)

Department of Public Health, University "Federico II" of Naples, Naples, Italy.
Interdepartmental Research Center in Healthcare Management and Innovation in Healthcare (CIRMIS), Naples, Italy.
Department of Primary Care and Public Health, School of Public Health, Imperial College, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH